EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

Tackling Post‐Endoscopy Gastric Cancer in a Low‐Risk Area: Prevalence, Features, and Prevention Opportunities Through Better Clinical Practice

Ricard Prat iD, Joan Llach iD, Sheyla Montori iD, Anabella Cuestas, Nayra Felípez iD, Alba Valero iD, Pedro Delgado-Guillena iD, Javier Tejedor-Tejada iD, Elena Arruebo, Silvia Patricia Ortega iD, Pilar Diez, Diana Zaffalon und 20 weitere

United European Gastroenterology Journal · 2025

DOI: 10.1002/ueg2.70096 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift United European Gastroenterology Journal, 2025. Verfasst von Ricard Prat und 31 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Barcelo…. Hauptthemen laut MEDLINE: Gastroscopy, Stomach Neoplasms. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Asociación Española de Gastroenterología, Instituto de Salud Carlos III, Acción Estratégica en Salud.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Post‐endoscopy gastric cancer (PEGC) is a gastric cancer (GC) diagnosed within 3 years after an esophago‐gastro‐duodenoscopy (EGD) negative for cancer. Post‐endoscopy gastric cancer has a prevalence of 9%–11% in the western population and is potentially reducible through adequate surveillance and high‐quality endoscopy. However, Post‐Endoscopy Gastric Cancer features are not well defined.

Objectives

Define Post‐Endoscopy Gastric Cancer prevalence in a gastric cancer low‐risk area as Spain, describe its characteristics and associated factors. Evaluate adherence to current recommendations for surveillance of preneoplastic gastric lesions and endoscopic quality indicators.

Methods

A descriptive and analytical study included patients who met PEGC criteria and enrolled in the EpiGASTRIC registry—a national multicentric GC cohort—between April 2021 and May 2024.

Results

Of 289 gastric cancer patients analyzed, 21 (7.3%) presented with PEGC. No differences were found between PEGCs and new‐onset gastric cancers (NOGC) regarding clinical‐demographic characteristics (males 52.4%, 65 years, caucasians 78.9%, previous Helicobacter pylori infection 56.3%) except for use of proton pump inhibitors (PPI) (81.0% vs. 44.9%, p ‐value = 0.002). Distal stomach (antrum and/or incisure) was more frequently affected in PEGC compared with NOGC (71.4% vs. 46.2%; p ‐value = 0.022), without differences in tumoral staging (I–II 52.4%) or histology (intestinal type 47.6%). Median time from last negative‐for‐cancer EGD to diagnosis was 13.6 months (interquartile range 4.1–26.8), with 38.1% of precursor lesions in previous endoscopy (19% chronic atrophic gastritis with metaplasia, 19% dysplasia). Considering last negative‐for‐cancer EGD, adherence to current recommendations was 66.6% for the surveillance of gastric lesions, and 14.3% for quality indicators (complete procedure 100%, high‐definition 38.1%, chromoendoscopy 10.0%).

Conclusions

PEGC patients present a higher rate of distal stomach involvement and use of PPIs. Although precursor gastric lesions are commonly identified, adherence to current recommendations for their surveillance and to established quality indicators in EGDs is scarce. Despite its low prevalence, there is room for improvement to enhance the early detection and prevention strategies for PEGC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GastroscopyStomach NeoplasmsAgedFemaleHumansMaleMiddle AgedEarly Detection of CancerGuideline AdherenceHelicobacter InfectionsPrecancerous ConditionsPrevalenceRegistriesRisk FactorsSpain

Stichwörter der Autor:innen

Spainendoscopic qualityendoscopyepidemiologygastric cancerpost‐endoscopy gastric cancerprecursor lesionsproton pump inhibitorssurveillanceupper gastrointestinal cancer

Autor:innen und Institutionen

  • Department of Gastroenterology, Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Barcelona, Spain.
  • Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain.
  • Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain.
  • Gastroenterology Research Unit, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Pamplona, Spain.
  • Department of Gastroenterology, Hospital de Mérida, Mérida, Spain.
  • Department of Gastroenterology, Hospital Universitario de Cabueñes, Gijón, Spain.

ORCID-Profile: Ricard Prat, Joan Llach, Sheyla Montori, Nayra Felípez, Alba Valero, Pedro Delgado-Guillena, Javier Tejedor-Tejada, Silvia Patricia Ortega, Luis Hernández, Gonzalo Hijos-Mallada, Astrid Irene Díez-Martín, Elisa Cantú-Germano, Francesc Balaguer

Förderung

  • Asociación Española de Gastroenterología
  • Instituto de Salud Carlos III
  • Acción Estratégica en Salud
  • Sociedad Española de Endoscopia Digestiva

Zitieren

APA

Prat, R., Llach, J., Montori, S., Cuestas, A., Felípez, N., Valero, A., Delgado-Guillena, P., Tejedor-Tejada, J., Arruebo, E., Ortega, S. P., Diez, P., Zaffalon, D., Hernández, L., Hontoria, G., Saíz, R. M., Hijos-Mallada, G., Domper Arnal, M. J., Zarraquiños, S., Díez-Martín, A. I., …, & EpiGASTRIC/EDGAR Consortium (2025). Tackling Post‐Endoscopy Gastric Cancer in a Low‐Risk Area: Prevalence, Features, and Prevention Opportunities Through Better Clinical Practice. United European Gastroenterology Journal. https://doi.org/10.1002/ueg2.70096

Vancouver

Prat R, Llach J, Montori S, Cuestas A, Felípez N, Valero A, et al. Tackling Post‐Endoscopy Gastric Cancer in a Low‐Risk Area: Prevalence, Features, and Prevention Opportunities Through Better Clinical Practice. United European Gastroenterology Journal. 2025. doi:10.1002/ueg2.70096

BibTeX
@article{Prat2025,
  author = {Prat, Ricard and Llach, Joan and Montori, Sheyla and Cuestas, Anabella and Felípez, Nayra and Valero, Alba and Delgado-Guillena, Pedro and Tejedor-Tejada, Javier and Arruebo, Elena and Ortega, Silvia Patricia and Diez, Pilar and Zaffalon, Diana and Hernández, Luis and Hontoria, Gadea and Saíz, Rosa María and Hijos-Mallada, Gonzalo and Domper Arnal, Maria Jose and Zarraquiños, Sara and Díez-Martín, Astrid Irene and Herreros, Alberto and de Frutos, Diego and Valentín, Fátima and Santiago, José and Piñol, Virginia and Martín-Lagos, Alicia and Luzko, Irina and Cantú-Germano, Elisa and Balaguer, Francesc and Fernández-Esparrach, Glòria and Albéniz, Eduardo and Moreira, Leticia and EpiGASTRIC/EDGAR Consortium, EpiGASTRIC/EDGAR Consortium},
  title = {Tackling Post‐Endoscopy Gastric Cancer in a Low‐Risk Area: Prevalence, Features, and Prevention Opportunities Through Better Clinical Practice},
  journal = {United European Gastroenterology Journal},
  year = {2025},
  doi = {10.1002/ueg2.70096}
}
Kostenlos starten →